Skip To Main Content
Alexandra Bartlett on Muck Rack

Alexandra Bartlett

As seen in: Nature, The BMJ, BioRxiv, Cell Press, Mondaq, Kennedys Early Careers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Alexandra

Contact Alexandra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Longitudinal multiomics profiling of extracorporeal cross-circulation with pig liver xenografts in human decedents

|
By Qian Guo, Chan Wang, Vincent Mauduit, Alexey Stukalov, Maede Mohebnasab, Alex Sagar, Simon Williams Verified, Berk Maden, Tal Eitan, Krista Barone, Jennifer D. Motter, Alexa K. Dowdell, Fred Robinson, Cyrille Guillot-Tantay, Justin Little, Kleio-Maria Verrou, Ángel Gálvez-Merchán, Peng Guo, Hui Gao, Austin G. Holmes, Alexandra Bartlett, Dong Xin, Hannah Futeran, Serafim Batzoglou, Shreyas Joshi, Mercy Rophina, Francesca Zanoni, Mohamed A. Elzawahry, John Fallon Verified, Syed Abbas, Kim M. Olthoff, Charles S. Abrams, Sagar Chhangawala, Adam D. Griesemer, Peter J Friend, Asim Rais Siddiqui, Eloi Schmauch, Brian D. Piening, Abraham Shaked, Brendan J. Keating, Susanna Vikman, Zasha Zayas, Kiana Moi, Emmry Stimson, Diana Argibay, Leah Wu
| Nature Verified
Abstract Extracorporeal liver cross-circulation (ELC) using gene-edited porcine liver xenografts offers a potential bridge therapy for liver failure. We previously performed five ELC procedures in four brain-dead human decedents, during which the recipients developed severe thrombocytopenia. The porcine liver xenografts maintained their parenchymal structure, with immune cell infiltration and detectable IgM deposition on endothelial cells.
Open in Who Shared Issue with article?

Bacillus Calmette–Guérin (BCG) immunotherapy reprograms CNS immunity and alters Alzheimer’s biomarkers: results from two open-label clinical trials

|
By Marc Weinberg Verified, Mahesh Chandra Kodali, Zhaozhi Li, Arianna R. Tidball, William Reynolds, Hadia Fatima, Pia Kivisäkk, Arpita Kulkarni, Alexandra Bartlett, Shannan Ho Sui, Willem M. Kühtreiber, Alison McManus, Rudolph E. Tanzi, Sudeshna Das, Denise L. Faustman, Steven Arnold, Jake A. Galler, Cathrine Young, Kelli Devitte- McKee, Mandovi Chatterjee, James M. Billingsly
| Nature Verified
Abstract Immune aging may contribute to Alzheimer’s disease. Bacillus Calmette–Guérin (BCG), a vaccine known to induce trained immunity, has been linked to reduced Alzheimer’s risk in prior studies. However, whether trained immunity can be observed in the human central nervous system remains unclear. We assessed whether BCG induces trained immunity–like responses in adults with and without Alzheimer’s-related changes.
Open in Who Shared Issue with article?

Kennedys recognised in the 2027 edition of Best Lawyers Australia and Singapore

|
By Matt Andrews, Mark Attard, Alexandra Bartlett, Nicholas Blackmore, Stephanie Cook, Chris Finn, Michael Kavanagh, Penny Taylor, Nicole Wearne, Mark Errington, Nick Francis, Alen Sinanovic, Kevin Kwek, Karnan Thirupathy, Anita Quy
| Kennedys Early Careers
Kennedys is pleased to have been recognised in the 2027 edition of Best Lawyers in Australia and Singapore.
Open in Who Shared Issue with article?
See all 15 articles